Move fast—April 30, 2025, is the final day to take advantage of early bird savings!
NeurologyLive® Staff
Advertisement
Articles by NeurologyLive® Staff
Here's some of what is coming soon to NeurologyLive® this week.
GENERATION HD2 Trial Amended, NeuroOne Completes Submission for OneRF Ablation System, FDA Authorizes Implantable Continuous EEG Monitoring System
Published: | Updated:
Neurology News Network. for the week ending April 26, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 25, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Valtoco Gains Expanded Indication, FDA Approves Digital Therapeutic for Migraine, Phase 1 Study of AMX0114 in ALS Begins
Published: | Updated:
Neurology News Network. for the week ending April 19, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 18, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Tividenofusp Alfa to be Submitted for Hunter Syndrome, Transcranial Stimulation Shows Efficacy in Alzheimer's, FDA Approves Pre-Filled Syringe for Efgartigimod
Published: | Updated:
Neurology News Network. for the week ending April 12, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 11, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Gamma Sensory Stimulation Preserves Corpus Callosum, P-Tau 217 and 181 Correlate With Clinical Outcomes, Lecanemab ARIA Risk Highest in Elevated Aß42/Total Tau Ratios
Published: | Updated:
Neurology News Network. for the week ending April 5, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 4, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
HEALEY-ALS Platform Trial Amended, WVE-N531 Improves Muscle Growth in DMD, Diazoxide Choline Approved for Prader-Willi Syndrome
Published: | Updated:
Neurology News Network. for the week ending March 29, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 28, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
New Study Testing Omaveloxolone in Pregnant Patients, Rozanolixizumab Improves Ocular Symptoms, Efgartigimod to be Studied in Juvenile MG
Published: | Updated:
Neurology News Network. for the week ending March 22, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 21, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Neflamapimod RewinD-LB Extension Data, CHMP Reaffirms Lecanemab Stance, Donanemab Associated With Increased ARIA Risk
Published: | Updated:
Neurology News Network. for the week ending March 15, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 14, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Pilavapadin Improves Diabetic Peripheral Neuropathic Pain, Application of 2025 McDonald Criteria, FDA Expands Eculizumab Indication to Pediatrics
Published: | Updated:
Neurology News Network. for the week ending March 8, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 7, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
FDA Approves Medtronic's Adaptive DBS, Hold Lifted on ELEVATE-44-102 Trial, Ecopipam Meets Primary and Secondary End Points in Tourette
Published: | Updated:
Neurology News Network. for the week ending March 1, 2025. [WATCH TIME: 3 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 28, 2025.
Here's some of what is coming soon to NeurologyLive® this week.
Harmony Receives RTF Letter for Pitolisant, FDA Accepts Vatiquinone NDA, Gene Therapy SGT-003 Performs Well in Phase 1/2 Trial
Published: | Updated:
Neurology News Network. for the week ending February 23, 2025. [WATCH TIME: 3 minutes]
Advertisement
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease
2
Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program
3
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
4
Fenebrutinib Demonstrates Strong Efficacy, Favorable Safety in FENhance MS Trials: Jacqueline Nicholas, MD
5